Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.

[1]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. , 1993, Journal of the National Cancer Institute.

[2]  A S Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[3]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[4]  J Halpern,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[5]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[6]  K. Kerlikowske,et al.  Should women with familial ovarian cancer undergo prophylactic oophorectomy? , 1992, Obstetrics and gynecology.

[7]  D. Cramer,et al.  Perineal Exposure to Talc and Ovarian Cancer Risk , 1992, Obstetrics and gynecology.

[8]  J. Stanford,et al.  Depot‐medroxyprogesterone acetate (DMPA) and risk of edometrial cancer , 1991, International journal of cancer.

[9]  G. Belle,et al.  Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer , 1991, The Lancet.

[10]  J. Schlesselman.  Oral contraceptives and neoplasia of the uterine corpus. , 1991, Contraception.

[11]  S. Shapiro,et al.  Endometrial cancer and age at last delivery: evidence for an association. , 1991, American journal of epidemiology.

[12]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[13]  D. Parkin.  Cancers of the breast, endometrium and ovary: geographic correlations. , 1989, European journal of cancer & clinical oncology.

[14]  W. Willett,et al.  GALACTOSE CONSUMPTION AND METABOLISM IN RELATION TO THE RISK OF OVARIAN CANCER , 1989, The Lancet.

[15]  D. Trichopoulos,et al.  A case‐control study of cancer of endometrium in athens , 1989, International journal of cancer.

[16]  A. Whittemore,et al.  Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. , 1988, American journal of epidemiology.

[17]  A. Whittemore,et al.  Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. , 1988, American journal of epidemiology.

[18]  W. Thompson,et al.  Familial ovarian cancer: a population-based case-control study. , 1988, American journal of epidemiology.

[19]  M. Pike,et al.  The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.

[20]  C. la Vecchia,et al.  Nutrition and diet in the etiology of endometrial cancer , 1986, Cancer.

[21]  C. la Vecchia,et al.  Risk factors for endometrial cancer at different ages. , 1984, Journal of the National Cancer Institute.

[22]  J. Kelsey,et al.  Breast and Gynecologic Cancer Epidemiology , 1983 .

[23]  J. Kelsey,et al.  A case-control study of cancer of the endometrium. , 1982, American journal of epidemiology.

[24]  N. Weiss,et al.  Incidence of endometrial cancer in relation to the use of oral contraceptives. , 1980, The New England journal of medicine.

[25]  D. English,et al.  Endometrial cancer in relation to patterns of menopausal estrogen use. , 1979, JAMA.

[26]  M. Modan,et al.  Possible role of mumps virus in the etiology of ovarian cancer , 1979, Cancer.

[27]  B. Stadel.  The etiology and prevention of ovarian cancer , 1975 .

[28]  M F Fathalla,et al.  Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.

[29]  W. Gardner.  Tumorigenesis in transplanted irradiated and nonirradiated ovaries. , 1961, Journal of the National Cancer Institute.

[30]  P. Horn-Ross,et al.  Multiple primary cancers involving the breast. , 1993, Epidemiologic reviews.

[31]  J L Kelsey,et al.  Breast cancer: magnitude of the problem and descriptive epidemiology. , 1993, Epidemiologic reviews.

[32]  L. Brinton,et al.  Estrogen replacement therapy and breast cancer risk. , 1993, Epidemiologic reviews.

[33]  W. Willett,et al.  Diet, body size, and breast cancer. , 1993, Epidemiologic reviews.

[34]  K. Malone.  Diethylstilbestrol (DES) and breast cancer. , 1993, Epidemiologic reviews.

[35]  K. Helzlsouer,et al.  Tamoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial. , 1993, Epidemiologic reviews.

[36]  J. Stanford,et al.  Exogenous progestins and breast cancer. , 1993, Epidemiologic reviews.

[37]  A. Oza,et al.  Mammographic parenchymal patterns: a marker of breast cancer risk. , 1993, Epidemiologic reviews.

[38]  C. Bodian.  Benign breast diseases, carcinoma in situ, and breast cancer risk. , 1993, Epidemiologic reviews.

[39]  J L Kelsey,et al.  Reproductive factors and breast cancer. , 1993, Epidemiologic reviews.

[40]  J L Kelsey,et al.  Radiation and other environmental exposures and breast cancer. , 1993, Epidemiologic reviews.

[41]  J. Kelsey.  Breast cancer epidemiology: summary and future directions. , 1993, Epidemiologic reviews.

[42]  N. Petrakis,et al.  Nipple aspirate fluid in epidemiologic studies of breast disease. , 1993, Epidemiologic reviews.

[43]  L. Bernstein,et al.  Endogenous hormones and breast cancer risk. , 1993, Epidemiologic reviews.

[44]  M. Pike,et al.  Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. , 1993, Epidemiologic reviews.

[45]  N. Weiss,et al.  Oral contraceptives in relation to breast cancer. , 1993, Epidemiologic reviews.

[46]  J. Palmer,et al.  Alcohol consumption and risk of breast cancer: a review of the epidemiologic evidence. , 1993, Epidemiologic reviews.

[47]  E. John,et al.  Recent etiologic hypotheses concerning breast cancer. , 1993, Epidemiologic reviews.

[48]  T. Tong,et al.  Cancer statistics, 1992 , 1992, CA: a cancer journal for clinicians.

[49]  M. Pike,et al.  The prevention of breast cancer through reduced ovarian steroid exposure. , 1992, Acta oncologica.

[50]  J. Kelsey,et al.  The epidemiology of breast cancer. , 1991, CA: a cancer journal for clinicians.

[51]  I. Cobden,et al.  初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験 , 1982 .

[52]  Paffenbarger Rs,et al.  Oral contraceptives and breast cancer risk. , 1979 .

[53]  Fathalla Mf.  Incessant ovulation--a factor in ovarian neoplasia? [letter] , 1971 .